Author

R. N. Kenfack

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. A. Z. Tiofack· 1 shared A. J. Njouendou· 1 shared E. H. M. D. Bell· 1 shared G. Simo· 1 shared J. D. Hoheisel· 1 shared J. T. Siveke· 1 shared S. N. Ananga· 1 shared S. S. Lueong· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. A. Z. Tiofack

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis

A. J. Njouendou, A. A. Z. Tiofack, R. N. Kenfack, S. N. Ananga, E. H. M. D. Bell, G. Simo, J. D. Hoheisel, J. T. Siveke, S. S. Lueong

The paper identifies SOX2 amplification as a driver of tumor aggressiveness by sustaining inflammation through the FOSL2/IL6 axis, leading to DNA damage and genome instability.

bioRxiv · Jun 9, 2022 · PreprintCancer Biology